Both in Pharmaceuticals
Cronos Group Inc. Common Share vs Mineralys Therapeutics
Over the past year CRON returned +51.8% and MLYS returned −61.6%; their daily moves had a correlation of 0.15.
CRON +51.8% MLYS −61.6%Growth of $1, one year, split-adjusted
| Metric | CRON | MLYS |
|---|---|---|
| Price | $3.72 | $15.24 |
| Market cap | $1.37B | $1.35B |
| Today | +5.98% | −10.35% |
| 1 month | +14.8% | −31.0% |
| 6 months | +44.7% | −48.1% |
| Year to date | +41.4% | −58.0% |
| 1 year | +51.8% | −61.7% |
| Revenue growth (YoY) | +59.5% | — |
| Gross margin | 65.8% | — |
| Net margin | 45.4% | — |
| P/E (TTM) | 19.6× | — |
| Price / sales | 5.3× | — |
| Net cash | $797.0M | $563.8M |
| Dividend yield | — | — |
| Volatility (60d) | 31.4% | 76.6% |
| Short % of float | 2.1% | 11.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).